Skip to content

Clinical trials

Respiratory Tract Diseases trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Country / region: Japan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20151
20161
20172
20191
20201
20211
20222
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Terminated5
Active, not recruiting4
Completed4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Eli Lilly and Company3
Blueprint Medicines Corporation2
Pfizer2
Upstream Bio Inc.2
Bellus Health Inc. - a GSK company1
Hoffmann-La Roche1
Mannkind Corporation1
Olympus Corporation1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases18
Lung Diseases17
Carcinoma, Bronchogenic7
Carcinoma, Non-Small-Cell Lung7
Lung Neoplasms7
Neoplasms7
Neoplasms by Site7
Respiratory Tract Neoplasms7
Thoracic Neoplasms7
Bronchial Diseases6

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.